South Korea

South Korea is a recognized hub for clinical research in the Asian region, with more clinical trials recorded than any other Asian country between 2001 and 2012.

George Clinical In South Korea

South Korea is a recognized hub for clinical research in the Asian region, with more clinical trials recorded than any other Asian country between 2001 and 2017

There are many government support structures for conducting research in Korea. This, coupled with a sophisticated infrastructure, a large population and a market size of approximately USD 20 billion, Korea attracts a large number of industry sponsors. Strong government support exists to encourage clinical trials in Korea.

Korea is the leading clinical trial destination in the Asian region. Between 2001 and 2012, Korea has the highest number of clinical trials compared to other Asian countries. Approximately 44.5 % of clinical trials in Korea are multinational trials in 2017

There is strong government support to develop Korean clinical trial capacity and capability, in particular to train clinical trial professionals and develop world-class sites.

The regulatory body responsible for administering the regulatory framework in Korea is the Ministry of Food and Drug Safety (MFDS). The MFDS has a policy of encouraging global trial participation and simultaneous global registration, which is evident from the many government incentives to promote international clinical trials. Only sites accredited by the MFDS may conduct clinical trials. As of August 2017, there are 184 accredited sites in Korea.

What are the benefits of conducting clinical trials in South Korea?

  • Leading clinical trial destination in the Asian region
  • Between 2001 and 2017, Korea has the highest number of CT compared to other Asian countries
  • Approximately 80% of CT in Korea are multinational trials
  • Fastest study start-up times in Asia, with well-defined regulatory and review processes

What are the prevalent diseases in South Korea?

  1. Stroke
  2. Coronary Heart disease
  3. Cancers
  4. Diabetes mellitus
  5. Alzheimer/Dementia
  6. Hypertension
  7. Kidney disease

Staff Experience in South Korea

Cardiovascular 64%

Central Nervous System 27%

Medical Devices 18%

Endocrinology 64%

Oncology 73%

Respiratory 55%

Nephrology 27%

Contact

Address:
4th FL, George Clinical Asia Pacific Limited
S&M building, 120, Myeongdal-ro, Seocho-gu,
Seoul 06658, Republic of Korea

Details

Population 51 million
Number of Personnel 10
Official Language Korean, English (widely taught in junior high and high school)
Hospital Records Language Korean (English commonly used in professional settings)
Electronic Hospital Records Approximately 80% of sites approved for clinical trials have an electronic medical record system. The rest is in the process of transition.
Site Network Only accredited sites are able to carry out human clinical trials. As of August 2017, there are 184 accredited sites in Korea.
In-country services Project Management
Clinical Operations
Regulatory Services
GDP – per capita (US $) $32,775
Health Expenditures 7.2% of GDP
George Clinical

1-901-259-0888

Profits from George Clinical support the work of The George Institute for Global Health.

Join our Mailing List

Add George Clinical to your network